Condition
POTS
Total Trials
6
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Unknown2
Active Not Recruiting1
Not Yet Recruiting1
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07405515Not ApplicableActive Not RecruitingPrimary
Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and COVID-19
NCT05796154Not ApplicableNot Yet RecruitingPrimary
POTS Stroke Volume
NCT02018497Unknown
Essential Hypotension and Allostasis Registry
NCT03261570Early Phase 1Completed
Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
NCT05398952Unknown
Post-COVID-19 Outpatient Care and Biomarkers
NCT04702217Not ApplicableWithdrawnPrimary
Physical Activity as a Complementary Treatment in POTS
Showing all 6 trials